Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial.
J Nutr Health Aging. 2009 Mar;13(3):242-8. doi: 10.1007/s12603-009-0066-1.
J Nutr Health Aging. 2009.
PMID: 19262961
Free article.
Clinical Trial.
Single versus multicomponent intervention in frail elderly: simplicity or complexity as precondition for success?
Vliek S, Melis RJ, Faes M, Golüke-Willemse GA, de Leest BJ, Meeuwsen E, van Raak FH, Schölzel-Dorenbos CJ, Olde Rikkert MG.
Vliek S, et al.
J Nutr Health Aging. 2008 May;12(5):319-22. doi: 10.1007/BF02982662.
J Nutr Health Aging. 2008.
PMID: 18443714
Free article.
Item in Clipboard
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
Vliek S, Hilbers FS, van Werkhoven E, Mandjes I, Kessels R, Kleiterp S, Lips EH, Mulder L, Kayembe MT, Loo CE, Russell NS, Vrancken Peeters MTFD, Holtkamp MJ, Schot M, Baars JW, Honkoop AH, Vulink AJE, Imholz ALT, Vrijaldenhoven S, van den Berkmortel FWPJ, Meerum Terwogt JM, Schrama JG, Kuijer P, Kroep JR, van der Padt-Pruijsten A, Wesseling J, Sonke GS, Gilhuijs KGA, Jager A, Nederlof P, Linn SC.
Vliek S, et al.
NPJ Breast Cancer. 2023 Sep 9;9(1):75. doi: 10.1038/s41523-023-00580-9.
NPJ Breast Cancer. 2023.
PMID: 37689749
Free PMC article.
Item in Clipboard
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.
Vliek SB, Hilbers FS, Jager A, Retèl VP, Bueno de Mesquita JM, Drukker CA, Veltkamp SC, Zeillemaker AM, Rutgers EJ, van Tinteren H, van Harten WH, van 't Veer LJ, van de Vijver MJ, Linn SC.
Vliek SB, et al.
Eur J Cancer. 2022 Nov;175:169-179. doi: 10.1016/j.ejca.2022.07.036. Epub 2022 Sep 17.
Eur J Cancer. 2022.
PMID: 36126477
Free article.
Item in Clipboard
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial.
Vliek SB, Noordhoek I, Meershoek-Klein Kranenbarg E, van Rossum AGJ, Dezentje VO, Jager A, Hokken JWE, Putter H, van der Velden AWG, Hendriks MP, Bakker SD, van Riet YEA, Tjan-Heijnen VCG, Portielje JEA, Kroep JR, Nortier JWR, van de Velde CJH, Linn SC.
Vliek SB, et al.
J Clin Oncol. 2022 Sep 1;40(25):2934-2945. doi: 10.1200/JCO.21.00311. Epub 2022 Apr 20.
J Clin Oncol. 2022.
PMID: 35442755
Clinical Trial.
Item in Clipboard
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet. 2019 Apr 6;393(10179):1440-1452. doi: 10.1016/S0140-6736(18)33137-4. Epub 2019 Feb 8.
Lancet. 2019.
PMID: 30739743
Free PMC article.
Item in Clipboard
Cite
Cite